Notice to Readers: Revised Recommendations of the Advisory
View PDF | Print View
by: Guest
Total views: 62
Word Count: 1013
MMWR. 2007;56:794-795
In January 2005, a quadrivalent meningococcal polysaccharide-protein conjugate vaccine (MCV4) (MenactraTM, Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed for use among persons aged 11-55 years. In May 2005, the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination with 1 dose of MCV4 for persons aged 11-12 years, persons entering high school (i.e., at approximately age 15 years) if not previously vaccinated with MCV4, and other persons at increased risk for meningococcal disease, including college freshmen living in dormitories.
ACIP continues to recommend routine vaccination for persons aged 19-55 years who are at increased risk for meningococcal disease: college freshmen living in dormitories, microbiologists routinely exposed to isolates of Neisseria meningitidis, military recruits, travelers to or residents of countries in which N. meningitidis meningitis is hyperendemic or epidemic, persons with terminal complement component deficiencies, and persons with anatomic or functional asplenia.
The ACIP goal is routine vaccination of all adolescents with MCV4 beginning at age 11 years. ACIP and partner organizations, including the American Academy of Pediatrics, American Academy of Family Physicians, American Medical Association, and Society for Adolescent Medicine, recommend a health-care visit for children aged 11-12 years to receive recommended vaccinations and indicated preventive services. This visit is the optimal time for adolescents to receive MCV4. In addition, because the incidence of meningococcal disease increases during adolescence, health-care providers should vaccinate previously unvaccinated persons aged 11-18 years with MCV4 at the earliest possible health-care visit. College freshmen living in dormitories are at increased risk for meningococcal disease and should be vaccinated with MCV4 before college entry if they have not been vaccinated previously. Because of difficulties in targeting freshmen in dormitories, colleges may elect to target their vaccination campaigns to all matriculating freshmen.
The ACIP meningococcal vaccine workgroup reviewed updated data on MCV4 use and supply projections and data presented previously on the epidemiology of meningococcal disease, safety, and the cost-effectiveness of MCV vaccination strategies. On the basis of these data, expert opinion of the workgroup members, and feedback from partner organizations, the workgroup revised the MCV4 recommendations, which were approved by ACIP at the June 2007 meeting.
The 2005 ACIP MCV4 recommendation was influenced by concern that implementation of MCV4 recommendations might be hindered by reduced vaccine supply during the first few years of production. In 2005 and 2006, peaks in demand were observed during the months when children were returning to school after summer vacation, leading to limited vaccine availability.
However, as of June 2007, ACIP expects supply of MCV4 to be sufficient to meet increased vaccine demand resulting from the revised recommendations. ACIP anticipates that recommending vaccination of all persons aged 11-18 years will improve MCV4 vaccination coverage in this age group and simplify provider decisions to vaccinate.
ACIP encourages health-care providers to vaccinate with MCV4 throughout the year to minimize seasonal increases in demand during July and August when students prepare to return to school from summer vacation. Vaccine providers should administer MCV4 and Tdap (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis) vaccine to persons aged 11-18 years during the same visit if both vaccines are indicated and available. If simultaneous vaccination is not feasible (e.g., a vaccine is not available), MCV4 and Tdap can be administered using any order of administration.
Persons with a history of GBS might be at increased risk for postvaccination GBS; therefore, a history of GBS is a relative contraindication to receiving MCV4. Persons recommended to receive meningococcal vaccination who have a history of GBS (or their parents) should discuss the decision to be vaccinated with their health-care provider.
Recommended books As a most domestic iron first Disillusionment often is the first one to Google News (including gossip) spread to the domestic people. I hope Google and Microsoft all the latest developments of interest to a friend dashed blog to see for yourself, disillusioned very hard, blog updates almost every day, I think the best way is the fastest on this information the Chinese blog. Today I went to Beijing interview Google! The process is very happy, finally received a gift from Google, Kai-fu Lee and Google book licensing ball-point pen. Do you want to write to express the disillusionment of a microphone, thanks, has insisted on doing so in targeted information and the exchange of information, I can go right today, it is very helpful, thank you.n
The first one is on the Google Health. - The anonymous sources said, he received from the Google news, Google Health as a new project is being developed, and similar to the current some specific Google search services such as video or music search, Google Health is a specialized medical treatment related to the search of new services. According to the anonymous speculation, Google Health is very likely to provide a self-help medical diagnosis search service. The second is on Google TV. Google recently started for the United States and the United Kingdom headquarters recruitment interactive television product manager for a television and related software engineers in the background, it will cause you to speculate Google launched Google TV. The anonymous sources and some other Google employees conversation, that the so-called Google TV is not like now, as Google Video is an online video service, it is likely to be integrated into the TV set-top box, or digital video equipment. Of course, or the main purpose of advertising. Do not forget Google deal with AOL, Google fully demonstrated the traditional media to enter ambitions. In fact, compared with Google TV, I am more interested in Google Health. Because first of all, if Google launched a TV and the domestic user experience may not be, and when Google Health introduction, perhaps one day, in your Google search: I head a halo, runny nose, body weakness Google will likely return: Maybe you had a cold. Please answer a few questions below, to further ascertain ... I think too much ...
Related: Notice to Readers: Revised Recommendations of the Advisory
Additional information:
From jama.ama-assn.org:
Alex loved the nutrition business and at the forefront was his determination that the Company continue to lead in nutritional.
Welcome. We have changed our name from Great Smokies Diagnostic Laboratory to Genova Diagnostics. This web site has not changed in content.
Chronic sinusitis paranasal sinuses lymph drainage conventional medicine functional disturbances causal chains galvanic currents causal.
Functional Medicine is a true holistic approach to helping people achieve. Functional Medicine starts with the idea that your body, mind and spirit.
Functional Medicine Services offered at Wellness Evolution, a new age health and wellness center located.
The doctor of the future will give no medicine, but will interest his patients in the care of the human frame, in diet, and in the cause and prevention.
These include family and emergency room doctor, practitioner of systems and functional medicine, chronically ill patient, advocate for sick parents.
Functional Diagnostic Medicine is a growing field of modern medicine. It offers a giant step forward in the diagnosis, treatment and prevention.
Rating:
Not yet rated
Comments
No comments posted.
Add Comment
You do not have permission to comment. If you
log in, you may be able to comment.
